
Anti-psychotic medications comprise between 30–50% of all psychotropics prescribed for people with learning disabilities. One of the potential side effects is metabolic syndrome (a group of risk factors that occur together and increase the risk for coronary artery disease, stroke and type 2 diabetes in people with learning disabilities who have been prescribed antipsychotic medication.) [read the full story…]